LIfT BioSciences has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.

A Nottingham regenerative medicine company which has developed a groundbreaking therapy that can help prevent sight loss has completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham.

The investment will allow NuVision Biotherapies to further develop its product range, strengthen its management team and increase sales in the UK and internationally.

NanoFlex Limited, an early stage sensor design company, has secured £250,000 of funding from NPIF – Maven Equity Finance, part of the Northern Powerhouse Investment Fund (NPIF).  The fund is delivered by MSIF working with Maven Capital Partners in the Liverpool City Region.

AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of neurodegenerative diseases including Alzheimer's disease, announced 14 million euros in series B funding led by Xerys.

BGF has provided an investment of £10m to CHS Healthcare, a leading national provider of specialist services for the NHS. The funding will be used to expand CHS’s infrastructure and operations, supporting the provision of services to the NHS nationwide.

BGF has made a significant minority investment in London Middlesex-based Revital, a multi-channel retailer of supplements, beauty and wellness products.

Backed by £9 million of investment capital from NVM Private Equity and a private US investor, Medovate is the first company dedicated to the development and commercialisation of innovative medical technologies from within the NHS, which will commercially benefit the NHS.

Discngine, a software company specializing in applications for life sciences research, today announces a Series A financing round of €1.1 million ($1.3M), received from Extens Développement e-Santé. The funds raised will allow Discngine to move forward with its Software-as-a-Service (SaaS) solution offering for the life sciences industry, a model that is not, as yet, widely used in this sector.

The developers of a communication platform that offers secure digital access to healthcare services have received £200,000 of seed funding in a deal led by Mercia Fund Management and involving the NHS-backed West Midlands Academic Health Science Networks (AHSNs) fund.

Footfalls & Heartbeats today announce a strategic investment round of £1.25m with The Enterprise Investment Scheme (EIS) tax relief. New product innovation is a key area of focus for Footfalls & Heartbeats, whose wearable technology is providing personalised, preventative healthcare, and solutions to aid the wellbeing of individuals.

Pharmacy2u.co.uk, the UK’s leading NHS approved online only pharmacy, has secured a further £7m of investment from BGF (Business Growth Fund) and other shareholders to continue to support the rapid growth of its home delivery repeat prescriptions service for NHS patients.

Vyaire Medical, the healthcare industry's largest pure-play "breathing" company, announced it has acquired Ciel Medical, a medical device company focused on solving unmet needs of medical professionals caring for intubated patients.